Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. Barron’s
Category: GLP-1 News
How the New Weight Loss Medications Change Our Relationship With Food – Yale School of Medicine
How the New Weight Loss Medications Change Our Relationship With Food Yale School of Medicine
How the New Weight Loss Medications Change Our Relationship With Food – Yale School of Medicine
How the New Weight Loss Medications Change Our Relationship With Food Yale School of Medicine
More claimants interested in weight-loss drugs; few are covered in comp – Business Insurance
More claimants interested in weight-loss drugs; few are covered in comp Business Insurance
Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’ – The Indian Express
Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’ The Indian Express
Zealand and Roche strike $5.3bn obesity treatment deal
The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in…
PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications – The Manila Times
PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications The Manila Times
Experts Finally Figured Out Why It’s So Common To Regain Weight. Here’s What You Can Do About It. – Women’s Health
Experts Finally Figured Out Why It’s So Common To Regain Weight. Here’s What You Can Do…
COVID Reflections, Novo’s Next-Gen Weight Loss Struggles, Another Depression Miss, More – BioSpace
COVID Reflections, Novo’s Next-Gen Weight Loss Struggles, Another Depression Miss, More BioSpace
Older adults face health risks from GLP-1 weight loss medications – WISH TV Indianapolis, IN
Older adults face health risks from GLP-1 weight loss medications WISH TV Indianapolis, IN